<!doctype html><html lang=tw><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><meta name=referrer content="no-referrer"><link rel=dns-prefetch href=https://i.geekbank.cf/><title>æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ | æå®¢å¿«è¨Š</title><meta property="og:title" content="æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ - æå®¢å¿«è¨Š"><meta property="og:type" content="article"><meta property="og:locale" content="tw"><meta property="og:image" content="https://p1.pstatp.com/large/pgc-image/de56ebe768384fb9b518ba6ba5678b7a"><link rel=alternate hreflang=x-default href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/4b93cacb.html><link rel=alternate hreflang=zh-tw href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/4b93cacb.html><link rel=alternate hreflang=zh-cn href=https://geekbank.cf/cn/%e7%a7%91%e6%8a%80/4b93cacb.html><link rel=alternate hreflang=zh-hk href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/4b93cacb.html><link rel=alternate hreflang=zh-mo href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/4b93cacb.html><link rel=alternate hreflang=zh-my href=https://geekbank.cf/cn/%e7%a7%91%e6%8a%80/4b93cacb.html><link rel=alternate hreflang=zh-sg href=https://geekbank.cf/cn/%e7%a7%91%e6%8a%80/4b93cacb.html><link rel=canonical href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/4b93cacb.html><meta property="article:published_time" content="2020-11-14T21:02:06+08:00"><meta property="article:modified_time" content="2020-11-14T21:02:06+08:00"><meta name=Keywords content><meta name=description content="æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡"><meta name=author content="æå®¢å¿«è¨Š"><meta property="og:url" content="/tw/%E7%A7%91%E6%8A%80/4b93cacb.html"><link rel=apple-touch-icon sizes=180x180 href=../../apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=../../favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=../../favicon-16x16.png><link rel=manifest href=../../site.webmanifest><link rel=mask-icon href=../../safari-pinned-tab.svg color=#5bbad5><meta name=msapplication-TileColor content="#ffc40d"><meta name=theme-color content="#ffffff"><link rel=stylesheet href=https://geekbank.cf/css/normalize.css><link rel=stylesheet href=https://geekbank.cf/css/style.css><script type=text/javascript src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js></script><script type=text/javascript src=https://geekbank.cf/js/jqthumb.min.js></script><script data-ad-client=ca-pub-3525055026201463 async src=https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js></script></head><body><header id=header class=clearfix><div class=container><div class=col-group><div class=site-name><h1><a id=logo href>ğŸ¤“ æå®¢å¿«è¨Š Geek Bank</a></h1><p class=description>ç‚ºä½ å¸¶ä¾†æœ€å…¨çš„ç§‘æŠ€çŸ¥è­˜ ğŸ§¡</p></div><div><nav id=nav-menu class=clearfix><a class=current href>çŒœä½ å–œæ­¡</a>
<a href=../../tw/categories/%E7%A7%91%E6%8A%80.html title=ç§‘æŠ€>ç§‘æŠ€</a>
<a href=../../tw/categories/%E9%81%8A%E6%88%B2.html title=éŠæˆ²>éŠæˆ²</a>
<a href=../../tw/categories/%E7%A7%91%E5%AD%B8.html title=ç§‘å­¸>ç§‘å­¸</a></nav></div></div></div></header><div id=body><div class=container><div class=col-group><div class=col-8 id=main><div class=res-cons><article class=post><header><h1 class=post-title>æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡</h1></header><date class="post-meta meta-date">2020-11-14</date><div class=post-meta><span>|</span>
<span class=meta-category><a href=tw/categories/%E7%A7%91%E6%8A%80.html>ç§‘æŠ€</a></span></div><div class=post-content><blockquote class=pgc-blockquote-abstract><p>æœ¬æ–‡ä½œè€…ï¼šå¼µåº·å¹³ï¼Œå¼µçªï¼Œæ–¼æ„·è‹±ï¼Œé™³æ°¸å…µï¼Œé¥’æœ¬å¼·ï¼ŒçŸ³æ¼¢å¹³ ï¼ˆé¦–éƒ½é†«ç§‘å¤§å­¸é™„å±¬åŒ—äº¬ä¸–ç´€å£‡é†«é™¢â€ƒèƒƒè…¸å¤–ç§‘ï¼ŒåŒ—äº¬â€ƒ100038ï¼‰</p><p>PDFä¸‹è¼‰éˆæ¥ï¼š</p><p>http://www.yixueqianyan.cn/CN/abstract/abstract3190.shtml</p></blockquote><blockquote class=pgc-blockquote-abstract><p>ã€æ‘˜è¦ã€‘â€ƒå²å“šèƒº2,3-é›™åŠ æ°§é…¶ï¼ˆindoleamine 2,3-dioxygenaseï¼ŒIDOï¼‰ä¸åƒ…æ˜¯å•Ÿå‹•è‰²æ°¨é…¸åˆ†è§£ä»£è¬çš„é—œéµé…¶ï¼Œä¹Ÿæ˜¯ä¸€ç¨®èˆ‡æ©Ÿé«”å¤–å‘¨å…ç–«è€å—ç¾è±¡å’Œæ©Ÿé«”å…ç–«æŠ‘åˆ¶ä½œç”¨ç›¸é—œçš„å…ç–«èª¿ç¯€é…¶ã€‚IDOä½œç‚ºä¸€ç¨®å…ç–«æŠ‘åˆ¶åˆ†å­ï¼Œåœ¨å¤šç¨®æƒ¡æ€§è…«ç˜¤çµ„ç¹”ä¸­é«˜è¡¨é”ï¼Œä¸¦èˆ‡ä¸è‰¯é å¾Œå¯†åˆ‡ç›¸é—œï¼Œå› æ­¤æœ‰æ•ˆæŠ‘åˆ¶IDOæ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ã€‚å°‡IDOæŠ‘åˆ¶åŠ‘èˆ‡æ‰‹è¡“ã€åŒ–ç™‚ã€æ”¾ç™‚ç­‰é€²è¡Œè¯åˆæ²»ç™‚ï¼Œæ˜¯è¿‘å¹´ä¾†ä¸æ–·è¢«æ¢ç©¶ä¸”å‰æ™¯è‰¯å¥½çš„è…«ç˜¤æ²»ç™‚æ–¹å‘ã€‚IDOæŠ‘åˆ¶åŠ‘ç¨®é¡ä¸»è¦åŒ…æ‹¬ï¼š1-ç”²åŸº-DL-è‰²æ°¨é…¸ï¼ˆ1-methyl-DL-tryptophanï¼Œ1-MTï¼‰å’Œepacadostatç‚ºä»£è¡¨çš„ç«¶çˆ­æ€§æŠ‘åˆ¶åŠ‘ï¼Œnavoximodç‚ºä»£è¡¨çš„éç«¶çˆ­æ€§æŠ‘åˆ¶åŠ‘ï¼Œä»¥åŠBMS-986205ã€exiguamine Aç­‰å…¶ä»–ç¨®é¡çš„æŠ‘åˆ¶åŠ‘ã€‚IDOæŠ‘åˆ¶åŠ‘ç¨®é¡ç¹å¤šï¼Œä½†é€²å…¥è‡¨åºŠè©¦é©—éšæ®µçš„è¼ƒå°‘ï¼Œæœ¬æ–‡ä¸»è¦é‡å°indoximodã€epacadostatã€navoximodã€BMS-986205å’ŒHTI-1090ç­‰IDOæŠ‘åˆ¶åŠ‘çš„è‡¨åºŠç ”ç©¶ç¾ç‹€é€²è¡Œé—¡è¿°ã€‚</p><p>ã€é—œéµè©ã€‘â€ƒå²å“šèƒº2,3-é›™åŠ æ°§é…¶ï¼›è…«ç˜¤ï¼›å²å“šèƒº2,3-é›™åŠ æ°§é…¶æŠ‘åˆ¶åŠ‘</p></blockquote><p><br></p><p>å…ç–«æ²»ç™‚ä»æ˜¯è…«ç˜¤æ²»ç™‚çš„æ´»èºé ˜åŸŸï¼Œéš¨è‘—äººå€‘å°è…«ç˜¤å¾®ç’°å¢ƒã€è…«ç˜¤å…ç–«é€ƒé€¸å’Œè…«ç˜¤å…ç–«è€å—ç­‰ç¾è±¡èªè­˜çš„é€æ­¥æ·±å…¥ï¼Œå‚™å—çŸšç›®çš„è…«ç˜¤å…ç–«æ²»ç™‚å·²åœ¨å…ç–«æª¢æŸ¥é»æŠ‘åˆ¶åŠ‘æ–¹é¢å–å¾—çªç ´æ€§é€²å±•ï¼Œç‰¹åˆ¥æ˜¯ç¨‹åºæ€§æ­»äº¡è›‹ç™½-1ï¼ˆprogrammed death protein-1ï¼ŒPD-1ï¼‰/ç¨‹åºæ€§æ­»äº¡è›‹ç™½é…é«”-1ï¼ˆprogrammed death ligÂ­aÂ­nd-1ï¼ŒPD-L1ï¼‰æŠ‘åˆ¶åŠ‘ã€ç´°èƒæ¯’Tæ·‹å·´ç´°èƒç›¸é—œæŠ—åŸ4ï¼ˆcytotoxic T lymphocyte-associated antigen-4ï¼ŒCTLA-4ï¼‰æŠ‘åˆ¶åŠ‘ç­‰ï¼Œç‚ºå…ç–«ç™‚æ³•è­œå¯«äº†å¶„æ–°ç¯‡ç« ã€‚å²å“šèƒº2,3-é›™åŠ æ°§é…¶ï¼ˆindoleamine 2ï¼Œ3-dioxygenaseï¼ŒIDOï¼‰ä½œç‚ºä¸€ç¨®æŠ‘åˆ¶æ€§å…ç–«æª¢æŸ¥é»ï¼Œè¢«ç™¼ç¾åœ¨è…«ç˜¤å¾®ç’°å¢ƒä¸­ç™¼æ®è‘—é‡è¦èª¿ç¯€ä½œç”¨ï¼Œå·²æˆç‚ºè…«ç˜¤å…ç–«æ²»ç™‚ä¸­é‡è¦çš„ç ”ç©¶ç›®æ¨™ã€‚</p><h1 class=pgc-h-arrow-right>1â€ƒIDOè¡¨é”èˆ‡èª¿ç¯€</h1><p>IDOæ˜¯L-è‰²æ°¨é…¸ï¼ˆL-tryptophanï¼ŒL-Trpï¼‰åˆ†è§£ä»£è¬ä¸»è¦é€”å¾‘ä¸­çš„é—œéµé™é€Ÿé…¶ï¼Œå¯å‚¬åŒ–L-è‰²æ°¨é…¸æ²¿çŠ¬å°¿æ°¨é…¸é€”å¾‘ä»£è¬ç”ŸæˆçŠ¬å°¿æ°¨é…¸åŠå…¶å¤šç¨®è¡ç”Ÿç‰©ï¼Œå¦‚å¯ç¶­æŒç´°èƒç©©æ…‹çš„ç…™é…°èƒºè…ºå˜Œå‘¤äºŒæ ¸è‹·é…¸[1,2]ã€‚IDOåŒæ™‚ä¹Ÿæ˜¯ä¸€ç¨®é‡è¦çš„å…ç–«èª¿ç¯€é…¶[3]ï¼Œå…¶é€šéç”Ÿæˆçš„ä»£è¬ç”¢ç‰©èª¿ç¯€æ©Ÿé«”å…ç–«ç³»çµ±ï¼Œç™¼æ®å…ç–«èª¿ç¯€ä½œç”¨ã€‚IDOæ˜¯ç”±äººé¡ç¬¬8è™ŸæŸ“è‰²é«”ä¸Šçš„INDOåŸºå› ç·¨ç¢¼çš„ç´°èƒå…§å«éµè¡€ç´…ç´ é…¶ï¼Œå«æœ‰403å€‹æ°¨åŸºé…¸ï¼Œç¸½åˆ†å­é‡ç´„ç‚º42 kDa[4]ã€‚IDOåŒ…æ‹¬å²å“šèƒº2,3-é›™åŠ æ°§é…¶1ï¼ˆindoleamine 2,3-dioxygenase 1ï¼ŒIDO1ï¼‰å’Œå²å“šèƒº2,3-é›™åŠ æ°§é…¶ 2ï¼ˆindoleamine 2,3-dioxygenase 2ï¼ŒIDO2ï¼‰ï¼Œå…¶ä¸­IDO2çš„èª¿æ§ä½œç”¨èˆ‡IDO1ä¸¦ä¸å®Œå…¨ä¸€è‡´ã€‚åœ¨æ­£å¸¸äººé«”ä¸­ï¼ŒIDOä¸»è¦åœ¨å°è…¸ã€å¥³æ€§ç”Ÿæ®–é“å’Œèƒç›¤ç­‰éƒ¨ä½å‘ˆä½è¡¨é”[5,6]ã€‚ç ”ç©¶è¡¨æ˜ï¼ŒIDOåœ¨è‚ºç™Œ[7]ã€é»‘è‰²ç´ ç˜¤[8]ã€ä¹³è…ºç™Œ[9]ã€åµå·¢ç™Œ[10]ã€é»˜å…‹çˆ¾ç´°èƒç™Œ[11]å’Œçµè…¸ç™Œ[12]ç­‰å¤šç¨®æƒ¡æ€§è…«ç˜¤æ‚£è€…é«”å…§æ´»æ€§å¢å¼·ï¼Œå‘ˆé«˜è¡¨é”ç‹€æ…‹ï¼Œä¸”IDOé«˜è¡¨é”èˆ‡é å¾Œè¼ƒå·®æœ‰é—œã€‚ç ”ç©¶è¡¨æ˜ï¼ŒIDOæ˜¯å°è‡´äººé«”å…§å¤–å‘¨å…ç–«è€å—çš„ä¸€ç¨®å…§æºæ€§æ©Ÿåˆ¶[13]ï¼Œä¹Ÿæ˜¯è…«ç˜¤å…ç–«æ²»ç™‚ä¸­é‡è¦çš„èª¿æ§é¶é»[14]ï¼Œèˆ‡ä¿ƒé€²è…«ç˜¤å…ç–«è€å—ã€è…«ç˜¤ç™¼å±•å’Œæƒ¡æ€§è…«ç˜¤ä¸è‰¯é å¾Œå¯†åˆ‡ç›¸é—œ[15-17]ã€‚å› æ­¤ï¼ŒIDOè¢«èªç‚ºæ˜¯ä¸€å€‹èƒ½å¤ å¢å¼·è…«ç˜¤å…ç–«æ²»ç™‚æ•ˆæœçš„æ–°é¶é»ã€‚åœ¨è…«ç˜¤å¾®ç’°å¢ƒä¸­ï¼ŒIDOé€šéè€—ç«­å±€éƒ¨å¾®ç’°å¢ƒä¸­çš„è‰²æ°¨é…¸ï¼Œé€²è€ŒæŠ‘åˆ¶çµ²/è˜‡æ°¨é…¸è›‹ç™½æ¿€é…¶â€”â€”å“ºä¹³å‹•ç‰©é›·å¸•é»´ç´ é¶è›‹ç™½æ•æ„Ÿå‹è¤‡åˆé«”1ï¼ˆmammalian target of rapaÂ­mÂ­ycin complex 1ï¼ŒmTORC1ï¼‰ï¼Œè‡´ä½¿Tæ·‹å·´ç´°èƒåŠŸèƒ½å–ªå¤±ï¼›ä¹Ÿå¯é€šéæ¿€æ´»ä¸€èˆ¬æ€§èª¿æ§é˜»éè›‹ç™½æ¿€é…¶2ï¼ˆgeneral control nonderepressible 2 kinaseï¼ŒGCN2ï¼‰ï¼Œå°è‡´æ•ˆæ‡‰Tç´°èƒå¢æ®–æ¸›å°‘[18,19]ã€‚æ­¤å¤–ï¼ŒIDOå‚¬åŒ–è‰²æ°¨é…¸åˆ†è§£ç”¢ç”Ÿçš„ä»£è¬ç”¢ç‰©å¯ä»¥æ¿€æ´»èŠ³é¦™çƒ´å—é«”AhRï¼ŒæŠ‘åˆ¶Tç´°èƒå¢æ®–[20,21]ã€‚IDOé‚„å¯ä»¥èª˜å°èª¿ç¯€æ€§Tç´°èƒæ“´å¢ï¼Œæ¿€æ´»èª¿ç¯€æ€§Tç´°èƒçš„å…ç–«æŠ‘åˆ¶åŠŸèƒ½[22,23]ã€‚åœ¨ä¸Šè¿°ä»£è¬é€šè·¯ä¸­ï¼ŒIDOæŠ‘åˆ¶åŠ‘ä¸»è¦é€šéèˆ‡è‰²æ°¨é…¸ç«¶çˆ­æ€§çµåˆIDOçš„å‚¬åŒ–çµæ§‹åŸŸæˆ–éç«¶çˆ­çš„æ©Ÿåˆ¶ä¾†å½±éŸ¿è‰²æ°¨é…¸çš„ä»£è¬ï¼Œé€²è€Œç™¼æ®å°IDOçš„æŠ‘åˆ¶ä½œç”¨ï¼ˆåœ–1ï¼‰ã€‚</p><p><br></p><div class=pgc-img><img alt=æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/de56ebe768384fb9b518ba6ba5678b7a><p class=pgc-img-caption></p></div><h1 class=pgc-h-arrow-right>2â€ƒIDOæŠ‘åˆ¶åŠ‘è‡¨åºŠç™¼å±•ç¾ç‹€</h1><p>ç•¶å‰å ±é“çš„å¤§å¤šæ•¸IDOæŠ‘åˆ¶åŠ‘ä»å°šæœªé€²å…¥è‡¨åºŠè©¦é©—éšæ®µï¼Œå·²ç¶“é€²å…¥è‡¨åºŠè©¦é©—éšæ®µçš„ä¸»è¦åŒ…æ‹¬indoximodï¼ˆ1-D-MTï¼Œå²å“šè«å¾·ï¼ŒNLG-8189ï¼‰ã€epacaÂ­dostatï¼ˆINCB024360ï¼‰ã€navoximodå’ŒBMS-986205ç­‰ã€‚ä»¥ä¸‹ä¸»è¦ä»‹ç´¹6ç¨®IDOæŠ‘åˆ¶åŠ‘å–®ä¸€æˆ–è¯åˆç”¨è—¥çš„è‡¨åºŠç ”ç©¶ç¾ç‹€ã€‚è¡¨1å½™ç¸½äº†ä¸»è¦è¨è«–çš„6ç¨®IDOæŠ‘åˆ¶åŠ‘ç›®å‰å…·æœ‰ä»£è¡¨æ€§çš„è‡¨åºŠè©¦é©—ä¿¡æ¯ã€‚</p><p><br></p><div class=pgc-img><img alt=æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/933daf5b854e412e9ac7acb63a04dec7><p class=pgc-img-caption></p></div><p><br></p><p><strong>2.1â€ƒindoximodâ€ƒ</strong>åˆç¨±1-D-MTï¼Œå²å“šè«å¾·ï¼ŒNLG-8189ï¼Œæ˜¯ç”±NewLink Geneticsï¼ˆNLNKï¼‰å…¬å¸ç ”ç™¼çš„æœ€å…·ä»£è¡¨æ€§çš„è‰²æ°¨é…¸é¡ä¼¼ç‰©æŠ‘åˆ¶åŠ‘ï¼ˆçµæ§‹å¼è¦‹åœ–2ï¼‰ã€‚1-MTæœ‰2ç¨®ç«‹é«”ç•°æ§‹é«”ï¼Œå³å·¦æ—‹é«”1-L-MTèˆ‡å³æ—‹é«”1-D-MTï¼ˆindoximodï¼‰ã€‚è‰²æ°¨é…¸æ¶ˆè€—å°‡å°è‡´mTORC1ä¿¡è™Ÿé€šè·¯å—åˆ°æŠ‘åˆ¶ï¼Œindoximodèƒ½å¤ æ¸›è¼•è©²æŠ‘åˆ¶ä½œç”¨ï¼Œæ¢å¾©mTORC1çš„æ´»æ€§ï¼Œå› æ­¤indoximodä¸¦éä½œç”¨æ–¼IDOæœ¬èº«ï¼Œè€Œæ˜¯é–“æ¥ç™¼æ®æŠ‘åˆ¶ä½œç”¨[18,25]ã€‚indoximodå–®è—¥æˆ–è¯åˆåŒ–ç™‚ï¼ˆindoximodèˆ‡å¤šè¥¿ä»–è³½è¯åˆï¼‰æ²»ç™‚æ™šæœŸä¹³è…ºç™Œæˆ–å…¶ä»–å¯¦é«”ç˜¤çš„â… æœŸè‡¨åºŠè©¦é©—çµæœè¡¨æ˜ï¼Œæ‚£è€…å°å…¶è€å—æ€§è‰¯å¥½[26,27]ã€‚ä¸€é …â… æœŸè‡¨åºŠè©¦é©—ï¼ˆNCT00567931ï¼‰è§€å¯Ÿäº†æ™šæœŸæƒ¡æ€§è…«ç˜¤æ‚£è€…å–®ç¨æ‡‰ç”¨indoximodæ²»ç™‚çš„æœ€å¤§è€å—åŠ‘é‡å’Œæ¯’æ€§ï¼Œç•¶è—¥ç‰©åŠ‘é‡é”2000 mgï¼Œæ¯æ—¥2æ¬¡ï¼Œçµ¦è—¥å¾Œ2.9 hæ™‚é”æœ€å¤§è¡€è—¥æ¿ƒåº¦ï¼Œç´„ç‚º12 Î¼mol/Lï¼Œè—¥ç‰©åŠè¡°æœŸç‚º10.5 hï¼Œå—è©¦çš„48ä¾‹æ‚£è€…ä¸­ï¼Œ5ä¾‹æ‚£è€…ç—…æƒ…ç©©å®šè¶…é6å€‹æœˆ[27,28]ã€‚</p><p><br></p><div class=pgc-img><img alt=æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/62ea7034c91b4593acb27337d0b7caa5><p class=pgc-img-caption></p></div><p>æç¤ºindoximodå…·æœ‰è‰¯å¥½çš„å£æœç”Ÿç‰©åˆ©ç”¨ç‡ã€å®‰å…¨æ€§å’Œè€å—æ€§ã€‚ä½†æœ‰ç ”ç©¶æŒ‡å‡ºï¼Œindoximodå–®è—¥å¹¾ä¹æ²’æœ‰ç™¼æ®æŠ—è…«ç˜¤ä½œç”¨ï¼Œè€Œèˆ‡å…¶ä»–æ²»ç™‚æ–¹æ³•è¯åˆä½¿ç”¨æ™‚ç™‚æ•ˆé¡¯è‘—å¢å¼·[13]ã€‚ä¸€é …é‡å°è½‰ç§»æ€§å»å‹¢æŠµæŠ—æ€§å‰åˆ—è…ºç™Œçš„éš¨æ©Ÿç ”ç©¶ï¼ˆNCT01560923ï¼‰ä¸­ï¼Œ46ä¾‹æ‡‰ç”¨æ¨¹çªç‹€ç´°èƒç–«è‹—å…ç–«ç™‚æ³•æ²»ç™‚çš„æ‚£è€…è¢«åˆ†ç‚ºå®‰æ…°åŠ‘çµ„ï¼ˆ24ä¾‹ï¼‰å’Œindoximodçµ„ï¼ˆ22ä¾‹ï¼‰ï¼Œçµæœé¡¯ç¤ºindoximodçµ„æ‚£è€…ç¸½ç”Ÿå­˜æœŸå»¶é•·è¶…é2å€ï¼Œä¸”æ‚£è€…å°è©²è—¥ç‰©çš„è€å—æ€§è‰¯å¥½ï¼Œå…©çµ„æ‚£è€…çš„ä¸è‰¯åæ‡‰ç„¡é¡¯è‘—å·®ç•°[29]ã€‚ç›®å‰IDOæŠ‘åˆ¶åŠ‘èˆ‡åŒ–ç™‚ã€æ”¾ç™‚è¯åˆæ²»ç™‚çš„è©¦é©—çµæœå–œæ†‚åƒåŠï¼Œæœ‰å¤šé …è¨»å†Šç ”ç©¶ä»åœ¨ç¹¼çºŒæ¢ç©¶IDOçš„è¯åˆæ²»ç™‚æ–¹æ¡ˆï¼ˆå¦‚NCT01792050ï¼ŒNCT02052648ï¼ŒNCT02077881ï¼ŒNCT02502708ï¼ŒNCT02835729ï¼‰ã€‚ç¸½æ‹¬è€Œè¨€ï¼Œindoximodæ˜¯ä¸€ç¨®å…·æœ‰å»£æ³›æ½›åœ¨ç”¨é€”çš„é‡è¦çš„IDOæŠ‘åˆ¶åŠ‘ï¼Œå…¶å®‰å…¨æ€§è¼ƒå¥½ï¼Œä¸¦æœ‰æœ›æ”¹å–„è…«ç˜¤æ²»ç™‚ç¾ç‹€[17]ï¼Œä½†è¯åˆæ²»ç™‚çš„æ–¹æ¡ˆæ‡‰ç¹¼çºŒé€²è¡Œè©¦é©—é©—è­‰ã€‚â€ƒ</p><p><strong>2.2â€ƒepacadostatâ€ƒ</strong>åˆåINCB024360ï¼Œæ˜¯ç”±Incyteå…¬å¸ç ”ç™¼çš„N-ç¾¥åŸºè„’é¡å…·æœ‰é«˜åº¦é¸æ“‡æ€§çš„IDOæŠ‘åˆ¶åŠ‘ï¼Œè©²æŠ‘åˆ¶åŠ‘æ˜¯ç›®å‰é–‹å±•ç ”ç©¶æœ€å¿«ã€æœ€æ·±å…¥çš„ä¸€ç¨®é«˜æ•ˆè‰²æ°¨é…¸ç«¶çˆ­æ€§IDOæŠ‘åˆ¶åŠ‘ï¼ˆçµæ§‹å¼è¦‹åœ–3ï¼‰ã€‚epacadostatå¯èˆ‡çŠ¬å°¿æ°¨é…¸çš„åº•ç‰©è‰²æ°¨é…¸ç«¶çˆ­çµåˆIDOçš„å‚¬åŒ–çµæ§‹åŸŸï¼Œç™¼æ®ç«¶çˆ­æ€§æŠ‘åˆ¶IDOçš„ä½œç”¨ï¼Œå¾è€Œæœ‰æ•ˆå¹²é è‰²æ°¨é…¸ä»£è¬éç¨‹ï¼Œä½¿å¾—æ•ˆæ‡‰Tç´°èƒå’Œè‡ªç„¶æ®ºå‚·ç´°èƒçš„å¢æ®–å¢å¼·ã€å‡‹äº¡æ¸›å°‘å’ŒCD86+æ¨¹çªç‹€ç´°èƒæ´»åŒ–å¢åŠ ï¼ŒåŒæ™‚æŠ‘åˆ¶èª¿ç¯€æ€§Tç´°èƒçš„æ“´å¢[30]ã€‚</p><p><br></p><div class=pgc-img><img alt=æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/ee5e451e097b41a5ab25939bd2ad7952><p class=pgc-img-caption></p></div><p><br></p><p>epacadostatä¸»è¦ç”¨æ–¼åµå·¢ç™Œã€é»‘è‰²ç´ ç˜¤ã€éª¨é«“å¢ç”Ÿç•°å¸¸ç¶œåˆå¾µç­‰çš„æ²»ç™‚ã€‚ç ”ç©¶é¡¯ç¤ºï¼Œepacadostatåœ¨ç´°èƒå…§æŠ‘åˆ¶IDO1çš„åŠæ•¸æœ‰æ•ˆæ¿ƒåº¦å°IDO2å’Œè‰²æ°¨é…¸2,3-é›™åŠ æ°§é…¶ï¼ˆtryptophan 2,3-dioxygenaseï¼ŒTDOï¼‰çš„æŠ‘åˆ¶ä½œç”¨å¾ˆå¼±ï¼Œè­‰æ˜å…¶å°IDO1ä½œç”¨ç‰¹ç•°æ€§è¼ƒå¼·[31]ã€‚NCT01195311ç ”ç©¶ç‚ºepacadostatçš„â… æœŸè‡¨åºŠåŠ‘é‡éå¢è©¦é©—ï¼Œ52ä¾‹æ™šæœŸæƒ¡æ€§å¯¦é«”ç˜¤æ‚£è€…æœç”¨è©²è—¥æ²»ç™‚ï¼ŒåŠ‘é‡ç‚º50 mgæ¯æ—¥1æ¬¡æˆ–50ã€100ã€300ã€400ã€500ã€600æˆ–700 mgæ¯æ—¥2æ¬¡ï¼Œä¸¦åœ¨ç‚ºæœŸ28 dçš„æ²»ç™‚é€±æœŸå…§é€²è¡Œè©•ä¼°ï¼Œçµæœé¡¯ç¤º7ä¾‹æ‚£è€…ç—…æƒ…ç©©å®šæŒçºŒ16å‘¨ï¼ˆ112 dï¼‰ä»¥ä¸Šï¼Œæç¤ºepacadostatè€å—æ€§è‰¯å¥½[32]ã€‚</p><p>ç‚ºäº†æ¢ç©¶epacadostatçš„å®‰å…¨æ€§å’Œçµ¦è—¥æ–¹æ¡ˆï¼Œç ”ç™¼è€…å¾ŒçºŒé–‹å±•äº†å¤šé …â…¡æœŸè‡¨åºŠè©¦é©—ã€‚åœ¨éš¨æ©Ÿé›™ç›²çš„ECHO-301è©¦é©—ä¸­[33-35]ï¼Œepacadostatèˆ‡å¸•åšåˆ©ç å–®æŠ—è¯åˆç”¨æ–¼æ²»ç™‚è½‰ç§»æ€§é»‘è‰²ç´ ç˜¤çš„â…¡æœŸè‡¨åºŠè©¦é©—çµæœä¸¦ä¸ç†æƒ³ï¼Œè©²çµ„åˆæœªæ”¹å–„ä¸­ä½ç„¡é€²å±•ç”Ÿå­˜æœŸçš„ä¸»è¦çµ‚é»ï¼Œç¸½ç”Ÿå­˜æœŸä¹Ÿç„¡é¡¯è‘—å·®ç•°ï¼Œè‡´ä½¿ç ”ç©¶æå‰çµ‚æ­¢[34]ã€‚åœ¨è½‰ç§»æ€§é»‘è‰²ç´ ç˜¤æ‚£è€…çš„â…¢æœŸéš¨æ©Ÿé›™ç›²è©¦é©—ï¼ˆECHO-301/KEYNOTE-252ï¼‰ä¸­ï¼Œèˆ‡å®‰æ…°åŠ‘ï¼‹å¸•åšåˆ©ç å–®æŠ—çµ„ç›¸æ¯”ï¼Œepacadostatï¼ˆ100 mgï¼Œæ¯æ—¥2æ¬¡ï¼‰ï¼‹å¸•åšåˆ©ç å–®æŠ—ä¸¦ä¸èƒ½æ”¹å–„ç„¡é€²å±•ç”Ÿå­˜æœŸæˆ–ç¸½ç”Ÿå­˜æœŸï¼Œèªç‚ºé€šéæŠ‘åˆ¶IDOä½œç‚ºå¢å¼·æŠ—PD-1æ²»ç™‚æ´»æ€§çš„æ–¹æ¡ˆçš„æœ‰æ•ˆæ€§ä»ç„¶ä¸ç¢ºå®š[33]ã€‚</p><p>ä½†åœ¨epacadostatèˆ‡å¸•åšåˆ©ç å–®æŠ—è¯åˆä½¿ç”¨çš„â… æœŸè‡¨åºŠè©¦é©—ä¸­ï¼Œå…±ç´å…¥62ä¾‹â…¢BæœŸã€â…£æœŸæˆ–è¤‡ç™¼æ€§è…«ç˜¤ï¼ˆåŒ…æ‹¬éå°ç´°èƒè‚ºç™Œã€é»‘è‰²ç´ ç˜¤ç­‰ï¼‰æ‚£è€…ï¼Œ8ä¾‹æ‚£è€…é”åˆ°å®Œå…¨ç·©è§£çš„æœ€ä½³çµæœï¼Œ17ä¾‹æ‚£è€…å¯¦ç¾äº†éƒ¨åˆ†ç·©è§£ï¼Œ15ä¾‹æ‚£è€…å‡ºç¾å®¢è§€åæ‡‰ã€‚84%çš„æ‚£è€…å‡ºç¾æ²»ç™‚ç›¸é—œä¸è‰¯åæ‡‰ï¼Œä¸»è¦ç‚ºç–²å‹ã€çš®ç–¹ç­‰ï¼Œ24%çš„æ‚£è€…å‡ºç¾äº†3ï½4ç´šä¸è‰¯åæ‡‰[36]ã€‚ç¸½é«”ä¾†çœ‹ï¼Œepacadostatè¯åˆå¸•åšåˆ©ç å–®æŠ—åœ¨ä¸€äº›è©¦é©—ä¸­è¡¨ç¾å‡ºè‰¯å¥½çš„è€å—æ€§ï¼Œä¸”åœ¨æ™šæœŸå¯¦é«”ç˜¤ä¸­æœ‰æŠ—è…«ç˜¤ä½œç”¨[36]ã€‚å³ä½¿epacadostatåœ¨â… /â…¡æœŸè‡¨åºŠè©¦é©—ä¸­å…·æœ‰è‰¯å¥½çµæœï¼Œä½†å…¶æœªä¾†èƒ½å¦åœ¨â…¢æœŸè‡¨åºŠè©¦é©—ä¸­ç²å¾—ç†æƒ³çµæœï¼Œé‚„éœ€ç­‰å¾…æ­£åœ¨é€²è¡Œä¸­çš„è‡¨åºŠè©¦é©—ç™¼ä½ˆçµæœä¸¦å°å…¶é€²è¡Œç¶œåˆè©•åƒ¹ã€‚</p><p><strong>2.3â€ƒnavoximodâ€ƒ</strong>åˆåGDC-0919ï¼ŒNLG-919ï¼Œæ˜¯ç”±NewLink Geneticså…¬å¸ç ”ç™¼çš„ä¸€ç¨®æ´»æ€§è¼ƒå¥½çš„éç«¶çˆ­æ€§IDOæŠ‘åˆ¶åŠ‘ï¼Œå«æœ‰è‰²æ°¨é…¸IDOæŠ‘åˆ¶åŠ‘çš„4-è‹¯åŸºå’ªå”‘çµæ§‹ï¼Œå…¶è¼ƒepacadostatå’ŒBMS-986205å…·æœ‰æ›´å¼·çš„æŠ—IDOæ´»æ€§ï¼ˆçµæ§‹å¼è¦‹åœ–4ï¼‰ã€‚navoximodç›®å‰è™•æ–¼â… æœŸè‡¨åºŠç ”ç©¶éšæ®µï¼Œæ‡‰ç”¨æ–¼è¤‡ç™¼æ€§å¯¦é«”ç˜¤çš„æ²»ç™‚ã€‚</p><p><br></p><div class=pgc-img><img alt=æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/5c7efefeca444a0eb30665fbb4877eee><p class=pgc-img-caption></p></div><p><br></p><p>Maç­‰[37]ç ”ç©¶ç™¼ç¾ï¼Œnavoximodå¸æ”¶è¿…é€Ÿä¸¦ä¸”å…·æœ‰è‰¯å¥½çš„è€å—æ€§ã€‚ä¸€é …é‡å°è¤‡ç™¼æ€§æ™šæœŸå¯¦é«”ç˜¤æ‚£è€…çš„â… æœŸè‡¨åºŠç ”ç©¶çµæœé¡¯ç¤ºï¼Œnavoximodåœ¨é«˜é”800 mgã€æ¯æ—¥2æ¬¡çš„åŠ‘é‡ä¸‹ä»å…·æœ‰è‰¯å¥½çš„è€å—æ€§ï¼Œèƒ½æœ‰æ•ˆé™ä½è¡€æ¼¿çŠ¬å°¿æ°¨é…¸æ°´å¹³ï¼Œä¸¦ä¸”è§€å¯Ÿåˆ°ç–¾ç—…ç©©å®š[38]ã€‚ç„¶è€Œï¼Œ2017å¹´ç¾åœ‹è‡¨åºŠè…«ç˜¤å­¸æœƒå¹´æœƒæ‰€å…¬ä½ˆçš„navoximodè¯åˆç´«æ‰é†‡æ²»ç™‚è½‰ç§»æ€§ä¹³è…ºç™Œçš„â…¡æœŸè‡¨åºŠç ”ç©¶çµæœé¡¯ç¤ºï¼Œè©²çµ„åˆåœ¨ç„¡é€²å±•ç”Ÿå­˜æœŸã€ç¸½ç”Ÿå­˜æœŸã€å®¢è§€ç·©è§£ç‡ç­‰æŒ‡æ¨™ä¸­å‡æœªé¡¯ç¤ºæœ‰çµ±è¨ˆå­¸æ„ç¾©ã€‚ä½†æ˜¯ï¼ŒJungç­‰[39]é–‹å±•çš„æ™šæœŸå¯¦é«”ç˜¤çš„â… æœŸè‡¨åºŠç ”ç©¶çµæœé¡¯ç¤ºï¼Œatezolizumabè¯åˆnavoximodæ²»ç™‚å°æ–¼æ™šæœŸå¯¦é«”ç˜¤æ‚£è€…å…·æœ‰è‰¯å¥½çš„å®‰å…¨æ€§å’Œå¯è€å—æ€§ã€‚å„˜ç®¡è©¦é©—ä¸­è§€å¯Ÿåˆ°äº†æŠ—è…«ç˜¤æ´»æ€§ï¼Œä½†æ²’æœ‰æ˜ç¢ºè­‰æ“šè¡¨æ˜atezolizumabè¯åˆnavoximodæ˜¯æœ‰ç›Šæ–¼æ²»ç™‚çš„ã€‚navoximodä»æ˜¯ä¸€ç¨®å…·æœ‰æ½›åŠ›çš„æ–°å‹å…ç–«æª¢æŸ¥é»æŠ‘åˆ¶åŠ‘ã€‚</p><p><strong>2.4â€ƒBMS-986205â€ƒ</strong>BMS-986205æ˜¯ç”±Bristol-Myers Squibbå…¬å¸æŠ•è³‡ç ”ç™¼çš„ä¸€ç¨®ç¨ç‰¹çš„IDOæŠ‘åˆ¶åŠ‘ï¼ˆçµæ§‹å¼è¦‹åœ–5ï¼‰ã€‚é«”å¤–è©¦é©—æ•¸æ“šè¡¨æ˜ï¼ŒBMS-986205å°IDOçš„æŠ‘åˆ¶æ•ˆæœå¥½[40,41]ã€‚NCT02658890ç ”ç©¶æ¯”è¼ƒBMS-986205å–®è—¥èˆ‡BMS-986205è¯åˆç´æ­¦åˆ©å°¤å–®æŠ—æ²»ç™‚é»‘è‰²ç´ ç˜¤çš„â… /â…¡æœŸç ”ç©¶ã€‚ä¸€ä»½ä¸­æœŸå ±å‘ŠæŒ‡å‡ºè©²åŒ–åˆç‰©åœ¨æ‚£è€…ä¸­è€å—æ€§è‰¯å¥½ã€‚åœ¨å…¶ä»–é¡å‹æ™šæœŸç™Œç—‡æ‚£è€…ä¸­ä¹Ÿé€²è¡Œäº†ç›¸åŒçµ„åˆçš„ç ”ç©¶ï¼ˆNCT03192943ï¼‰ï¼Œä¸¦æ–¼2018å¹´å®Œæˆï¼Œçµæœé¡¯ç¤ºBMS-986205å®‰å…¨æ€§å’Œè€å—æ€§å‡è‰¯å¥½ã€‚ç›®å‰å°‡BMS-986205è¯åˆç´æ­¦åˆ©å°¤å–®æŠ—æ²»ç™‚è‚ç™Œçš„è‡¨åºŠè©¦é©—æ­£åœ¨æ‹›å‹Ÿä¸­ï¼ˆNCT03695250ï¼‰[42]ã€‚</p><p><br></p><div class=pgc-img><img alt=æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/17cb179b62d1445a96805d35a68b6e0a><p class=pgc-img-caption></p></div><p><br></p><p>2.5â€ƒPF-06840003â€ƒPF-06840003æ˜¯ç”±è¼ç‘å…¬å¸ç ”ç™¼çš„éç«¶çˆ­æ€§ã€éè¡€ç´…è›‹ç™½çµåˆçš„IDOæŠ‘åˆ¶åŠ‘ï¼Œä¹Ÿæ˜¯ä¸€ç¨®ç”Ÿç‰©åˆ©ç”¨åº¦è¼ƒé«˜çš„é¸æ“‡æ€§IDOæŠ‘åˆ¶åŠ‘ï¼ˆçµæ§‹å¼è¦‹åœ–6ï¼‰ã€‚PF-06840003å¯ä»¥é€šéäººé«”è¡€-è…¦è„Šæ¶²å±éšœï¼Œå› æ­¤å°è…«ç˜¤è…¦è½‰ç§»å¯èƒ½æœ‰å¹²æ“¾å’ŒæŠ‘åˆ¶ä½œç”¨ã€‚åœ¨åŸºç¤ç ”ç©¶ä¸­ï¼ŒPF-06840003å¢å¼·äº†æŠ—è…«ç˜¤ä½œç”¨ã€‚ç›®å‰ï¼ŒPF-06840003å·²åœ¨æƒ¡æ€§è† è³ªç˜¤æ‚£è€…ä¸­é–‹å±•äº†â… æœŸè‡¨åºŠè©¦é©—ï¼ˆNCT02764151ï¼‰[43]ã€‚</p><p><br></p><div class=pgc-img><img alt=æœ‰æ•ˆæŠ‘åˆ¶é€™ç¨®é…¶çš„æ´»æ€§å¯å•Ÿå‹•é«”å…§æŠ—è…«ç˜¤å…ç–«åæ‡‰ï¼ç ”ç©¶ç¾ç‹€åœ¨é€™è£¡ onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/cbbac17301454a43956784e27ec740f0><p class=pgc-img-caption></p></div><p><br></p><p><strong>2.6â€ƒHTI-1090â€ƒ</strong>ä¹Ÿç¨±ç‚ºSHR9146ï¼Œæ˜¯ä¸€ç¨®æ–°å‹ä¸”é«˜æ•ˆçš„å°åˆ†å­IDO1/TDOé›™é‡æŠ‘åˆ¶åŠ‘ï¼Œå…¶çµæ§‹èˆ‡epacadostaté¡ä¼¼ï¼Œå…·æœ‰è‰¯å¥½çš„å£æœç”Ÿç‰©åˆ©ç”¨åº¦å’Œå®‰å…¨æ€§ï¼Œä¸€é …é—œæ–¼HTI-1090æ²»ç™‚æ™šæœŸå¯¦é«”ç˜¤çš„â… æœŸè‡¨åºŠè©¦é©—ï¼ˆNCT03208959ï¼‰å·²åœ¨2019å¹´1æœˆå®Œæˆã€‚</p><h1 class=pgc-h-arrow-right>3â€ƒå±•æœ›</h1><p>ç•¶å‰ä»æœ‰å¤šç¨®IDOæŠ‘åˆ¶åŠ‘æ­£åœ¨ç ”ç™¼ä¸­ã€‚å¦å¤–ï¼Œåœ¨è…«ç˜¤å…ç–«ç™‚æ³•ä¸­å°‡ç´ç±³æŠ€è¡“èˆ‡IDOæŠ‘åˆ¶åŠ‘ç›¸èåˆï¼Œå¾è€Œå¯¦ç¾æ›´ç²¾æº–çš„é¶å‘æ²»ç™‚æ—¢å…·æœ‰å‰æ™¯ä¹Ÿå…·æœ‰æŒ‘æˆ°æ€§[44,45]ã€‚IDOåœ¨èª˜å°å®¿ä¸»è…«ç˜¤å…ç–«è€å—åæ‡‰ä¸­çš„æ©Ÿåˆ¶è¤‡é›œå¤šæ¨£ï¼Œå¾ˆå¤šæœ‰é—œIDOèª¿æ§è…«ç˜¤å…ç–«çš„ç†è«–å’ŒçŒœæ¸¬ä»éœ€è¦é€²ä¸€æ­¥æ¢ç´¢ã€ç ”ç©¶èˆ‡è­‰å¯¦ã€‚æ­¤å¤–ï¼Œé—œæ–¼IDOæŠ‘åˆ¶åŠ‘çš„ç ”ç™¼é›–ç„¶å–å¾—äº†å¾ˆå¤§é€²å±•ï¼Œä½†IDOæŠ‘åˆ¶åŠ‘èˆ‡å‚³çµ±åŒ–ç™‚è—¥ç‰©ã€é¶å‘è—¥ç‰©ä»¥åŠå…ç–«ç™‚æ³•ã€æ”¾ç™‚é€²è¡Œè¯åˆæ²»ç™‚çš„æ•ˆæœä»éœ€é©—è­‰ã€‚</p><p><br></p><p>åƒè€ƒæ–‡ç»</p><p>[1] Munn DH, Mellor AL. IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance[J]. Trends Immunol, 2016, 37(3):193-207.</p><p>[2] King NJ, Thomas SR. Molecules in focus: indoleamine 2,3-dioxÂ­ygenase[J]. Int J Biochem Cell Biol, 2007, 39(12):2167-2172.</p><p>[3] Huang GL, Tao A, Miyazaki T, et al. PEG-Poly(1-Methyl-l-Tryptophan)-Based Polymeric Micelles as Enzymatically ActiÂ­vÂ­ated Inhibitors of Indoleamine 2,3-Dioxygenase[J]. NanoÂ­materials (Basel), 2019, 9(5).pii:E719.</p><p>[4] Najfeld V, Menninger J, Muhleman D, et al. Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12-->p11 by fluorescent in situ hybridization[J]. Cytogenet Cell Genet, 1993, 64(3-4):231-232.</p><p>[5] Theate I, van Baren N, Pilotte L, et al. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues[J]. Cancer Immunol Res, 2015, 3(2):161-172.</p><p>[6] Dai X, Zhu BT. Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions[J]. J Histochem Cytochem, 2010, 58(1):17-28.</p><p>[7] Tang D, Yue L, Yao R, et al. P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer[J]. OncoÂ­target, 2017, 8(33):54548-54557.</p><p>[8] Spranger S, Spaapen RM, Zha Y, et al. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells[J]. Sci Transl Med, 2013, 5(200): 200ra116.</p><p>[9] Carvajal-Hausdorf DE, Mani N, Velcheti V, et al. Objective measÂ­Â­uÂ­rÂ­ement and clinical significance of IDO1 protein in hormÂ­one receptor-positive breast cancer[J]. J Immunother Cancer, 2017, 5(1):81.</p><p>[10] å§œè±”éº—ï¼Œæ–¹è±”ç§‹ï¼Œè˜†å°å–®ï¼Œç­‰ï¼å²å“šèƒº2,3-é›™åŠ æ°§é…¶åœ¨è‰¯ã€æƒ¡æ€§åµå·¢è…«ç˜¤ä¸­çš„è¡¨é”åŠè‡¨åºŠæ„ç¾©[J]ï¼ä¸­åœ‹å©¦å¹¼ä¿å¥ï¼Œ2014ï¼Œ29ï¼ˆ36ï¼‰ï¼š6106-6108ï¼</p><p>[11] Wardhani LO, Matsushita M, Iwasaki T, et al. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma[J]. Hum Pathol, 2019, 84:52-61.</p><p>[12] Brandacher G, Perathoner A, Ladurner R, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells[J]. Clin Cancer Res, 2006, 12(4):1144-1151.</p><p>[13] Brochez L, Chevolet I, Kruse V. The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy[J]. Eur J Cancer, 2017, 76:167-182.</p><p>[14] Selvan SR, Dowling JP, Kelly WK, et al. Indoleamine 2,3-dioxy-</p><p>Â­genase (IDO): Biology and Target in Cancer ImmunotÂ­heraÂ­pies[J]. Curr Cancer Drug Targets, 2016, 16(9):755-764.</p><p>[15] Moon YW, Hajjar J, Hwu P, et al. Targeting the indoleamine 2,3-dioxygenase pathway in cancer[J]. J Immunother Cancer, 2015, 3:51.</p><p>[16] Pan K, Wang H, Chen MS, et al. Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2008, 134(11):1247-1253.</p><p>[17] Fox E, Oliver T, Rowe M, et al. Indoximod: An ImmunomÂ­etabolic Adjuvant That Empowers T Cell Activity in Cancer[J]. Front Oncol, 2018, 8:370.</p><p>[18] Metz R, Rust S, Duhadaway JB, et al. IDO inhibits a tryptoÂ­phan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan[J]. OncoiÂ­mmunology, 2012, 1(9):1460-1468.</p><p>[19] Muller AJ, DuHadaway JB, Donover PS, et al. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemoÂ­therapy[J]. Nat Med, 2005, 11(3):312-319.</p><p>[20] ç‹ç¿ å¨Ÿï¼Œå°šæ˜ï¼Œé‚µè¯ï¼èŠ³é¦™çƒ´å—é«”åœ¨è…«ç˜¤ç™¼ç”ŸåŠå…ç–«æ²»ç™‚ä¸­çš„ä½œç”¨[J]ï¼ä¸­è¯è…«ç˜¤é˜²æ²»é›œèªŒï¼Œ2018ï¼Œ25ï¼ˆ15ï¼‰ï¼š1126-1130ï¼</p><p>[21] Boitano AE, Wang J, Romeo R, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells[J]. Science, 2010, 329(5997):1345-1348.</p><p>[22] Dons EM, Raimondi G, Cooper DK, et al. Induced regulatory T cells: mechanisms of conversion and suppressive potential[J]. Hum Immunol, 2012, 73(4):328-334.</p><p>[23] Hill M, Tanguy-Royer S, Royer P, et al. IDO expands human CD4+CD25 high regulatory T cells by promoting maturation of LPS-treated dendritic cells[J]. Eur J Immunol, 2007, 37(11): 3054-3062.</p><p>[24] Prendergast GC, Malachowski WP, DuHadaway JB, et al. Discovery of IDO1 Inhibitors: From Bench to Bedside[J]. Cancer Res, 2017, 77(24):6795-6811.</p><p>[25] å‘¨æ˜ ç´…ï¼å°åˆ†å­IDO-1æŠ‘åˆ¶åŠ‘ç ”ç©¶é€²å±•[J]ï¼ä¸­åœ‹æŠ—ç”Ÿç´ é›œèªŒï¼Œ2016ï¼Œ41ï¼ˆ10ï¼‰ï¼š721-726ï¼</p><p>[26] Soliman HH, Jackson E, Neuger T, et al. A first in man phase â…  trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors[J]. Oncotarget, 2014, 5(18):8136-8146.</p><p>[27] Soliman HH, Minton SE, Han HS, et al. A phase â…  study of indoxÂ­imod in patients with advanced malignancies[J]. OncotÂ­arget, 2016, 7(16):22928-22938.</p><p>[28] ä»£éœ–éœ–ï¼Œæé¼•é¼•ï¼å°åˆ†å­è…«ç˜¤å…ç–«æ²»ç™‚è—¥ç‰©çš„è‡¨åºŠç ”ç©¶é€²å±•[J]ï¼ä¸­åœ‹æ–°è—¥èˆ‡è‡¨åºŠé›œèªŒï¼Œ2019ï¼Œ30ï¼ˆ8ï¼‰ï¼š455-463ï¼</p><p>[29] Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer[J]. N Engl J Med, 2010, 363(5):411-422.</p><p>[30] Liu X, Shin N, Koblish HK, et al. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity[J]. Blood, 2010, 115(17):3520-3530.</p><p>[31] Yue EW, Sparks R, Polam P, et al. INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology[J]. ACS Med Chem Lett, 2017, 8(5):486-491.</p><p>[32] Beatty GL, O'Dwyer PJ, Clark J, et al. First-in-Human Phase â…  Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies[J]. Clin Cancer Res, 2017, 23(13):3269-3276.</p><p>[33] Long GV, Dummer R, Hamid O, et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study[J]. Lancet Oncol, 2019, 20(8):1083-1097.</p><p>[34] Muller AJ, Manfredi MG, Zakharia Y, et al. Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond[J]. Semin Immunopathol, 2019, 41(1):41-48.</p><p>[35] No authors listed. Companies Scaling Back IDO1 Inhibitor Trials[J]. Cancer Discov, 2018, 8(7):OF5.</p><p>[36] Mitchell TC, Hamid O, Smith DC, et al. Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase â… /â…¡</p><p>Trial (ECHO-202/KEYNOTE-037)[J]. J Clin Oncol, 2018: JCO2018789602.</p><p>[37] Ma S, Suchomel J, Yanez E, et al. Investigation of the absolute bioavaÂ­ilability and human mass balance of navoximod, a novel IDO1 inhibitor[J]. Br J Clin Pharmacol, 2019, 85(8):1751-1760.</p><p>[38] Nayak-Kapoor A, Hao Z, Sadek R, et al. Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors[J]. J Immunother Cancer, 2018, 6(1):61.</p><p>[39] Jung KH, LoRusso P, Burris H, et al. Phase â…  Study of the Indo-Â­</p><p>leÂ­amine 2,3-Dioxygenase 1 (IDO1) Inhibitor NavoxÂ­imod (GDC-0919) Administered with PD-L1 Inhibitor (AtezoÂ­lizumab) in Advanced Solid Tumors[J]. Clin Cancer Res, 2019, 25(11):3220-3228.</p><p>[40] Pham KN, Yeh SR. Mapping the Binding Trajectory of a Suicide Inhibitor in Human Indoleamine 2,3-Dioxygenase 1[J]. J Am Chem Soc, 2018, 140(44):14538-14541.</p><p>[41] Richards T, Brin E. Cell based functional assays for IDO1 inhibitor screening and characterization[J]. Oncotarget, 2018, 9(56):30814-30820.</p><p>[42] Cheong JE, Ekkati A, Sun L. A patent review of IDO1 inhibÂ­itors for cancer[J]. Expert Opin Ther Pat, 2018, 28(4):317-330.</p><p>[43] Gomes B, Driessens G, Bartlett D, et al. Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy[J]. Mol Cancer Ther, 2018, 17(12):2530-2542.</p><p>[44] Zulfiqar B, Mahroo A, Nasir K, et al. Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors[J]. Oncol Targets Ther, 2017, 10:463-476.</p><p>[45] Feng B, Zhou F, Hou B, et al. Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment[J]. Adv Mater, 2018, 30(38):e1803001.</p></div><div class="post-meta meta-tags"><ul class=clearfix><li><a>é€™ç¨®</a></li><li><a>å•Ÿå‹•é«”</a></li><li><a>æŠ—è…«ç˜¤</a></li></ul></div></article></div></div><div id=secondary><section class=widget><form id=search action=//www.google.com/search method=get accept-charset=utf-8 target=_blank _lpchecked=1><input type=text name=q maxlength=20 placeholder=æœç´¢>
<input type=hidden name=sitesearch value=geekbank.cf>
<button type=submit>ğŸ”</button></form></section><section class=widget><h3 class=widget-title>æœ€æ–°æ–‡ç«  âš¡</h3><ul class=widget-list><li><a href=../../tw/%E7%A7%91%E6%8A%80/31e686d9.html alt=ä½ å®¶é‚„æœ‰é€™ç¨®ä¸€è§’ç´™å¹£å—ï¼Œå·²ç¶“ç¿»äº†å¹¾ç™¾å€äº†ï¼ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/6163000389a8a2ff98e1 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/31e686d9.html title=ä½ å®¶é‚„æœ‰é€™ç¨®ä¸€è§’ç´™å¹£å—ï¼Œå·²ç¶“ç¿»äº†å¹¾ç™¾å€äº†ï¼>ä½ å®¶é‚„æœ‰é€™ç¨®ä¸€è§’ç´™å¹£å—ï¼Œå·²ç¶“ç¿»äº†å¹¾ç™¾å€äº†ï¼</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/fed0d412.html alt=åƒé€™ç¨®æ‰æ˜¯çœŸæ­£çš„äº‹æ•…è»Šï¼Œé€£è»Šå•†çœ‹äº†éƒ½æ“ºæ‰‹ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/0dc1d19ce907426d8beca5bf1af1f2aa style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/fed0d412.html title=åƒé€™ç¨®æ‰æ˜¯çœŸæ­£çš„äº‹æ•…è»Šï¼Œé€£è»Šå•†çœ‹äº†éƒ½æ“ºæ‰‹>åƒé€™ç¨®æ‰æ˜¯çœŸæ­£çš„äº‹æ•…è»Šï¼Œé€£è»Šå•†çœ‹äº†éƒ½æ“ºæ‰‹</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/24a5d451.html alt=é‹¼ç­‹é‚„æœ‰é€™ç¨®åˆ†é¡ï¼Œä½ çŸ¥é“å—ï¼Ÿ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/pgc-image/0f5b15159ed64fbdaec886b70d828e11 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/24a5d451.html title=é‹¼ç­‹é‚„æœ‰é€™ç¨®åˆ†é¡ï¼Œä½ çŸ¥é“å—ï¼Ÿ>é‹¼ç­‹é‚„æœ‰é€™ç¨®åˆ†é¡ï¼Œä½ çŸ¥é“å—ï¼Ÿ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/7b679187.html alt=é€™ç¨®æ±‚çµæ§‹é«”æˆå“¡å¤§å°çš„æ–¹æ³•ä½ å¯èƒ½æ²’æŒæ¡ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/pgc-image/900a84ecc26a4d1d823c6a4a513cdc2d style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/7b679187.html title=é€™ç¨®æ±‚çµæ§‹é«”æˆå“¡å¤§å°çš„æ–¹æ³•ä½ å¯èƒ½æ²’æŒæ¡>é€™ç¨®æ±‚çµæ§‹é«”æˆå“¡å¤§å°çš„æ–¹æ³•ä½ å¯èƒ½æ²’æŒæ¡</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/02e9d5e7.html alt=é€™ç¨®é˜²æ°´è€ç£¨0ç”²é†›çš„åœ°æ¿ï¼Œä½ ä¸€å®šè¦äº†è§£ä¸€ä¸‹ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/1540800226853a9ff77a6fb style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/02e9d5e7.html title=é€™ç¨®é˜²æ°´è€ç£¨0ç”²é†›çš„åœ°æ¿ï¼Œä½ ä¸€å®šè¦äº†è§£ä¸€ä¸‹>é€™ç¨®é˜²æ°´è€ç£¨0ç”²é†›çš„åœ°æ¿ï¼Œä½ ä¸€å®šè¦äº†è§£ä¸€ä¸‹</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/a8471efd.html alt=é€™ç¨®é»ƒéŠ…ç¡¬å¹£ä½ å®¶æœ‰å—ï¼Ÿè³£å¾—æ¯”é»ƒé‡‘é‚„è²´ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/91a38d2dc6cb496682c861de5d83b4c0 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/a8471efd.html title=é€™ç¨®é»ƒéŠ…ç¡¬å¹£ä½ å®¶æœ‰å—ï¼Ÿè³£å¾—æ¯”é»ƒé‡‘é‚„è²´>é€™ç¨®é»ƒéŠ…ç¡¬å¹£ä½ å®¶æœ‰å—ï¼Ÿè³£å¾—æ¯”é»ƒé‡‘é‚„è²´</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/4ad8b035.html alt=å‹•è¼’ä¸Šç™¾å¡Šçš„é±’é­šç§‹æµ·æ£ ï¼Œé€™ç¨®ç¶²ç´…æ¤ç‰©å¾ˆå®¹æ˜“ç¹æ®–ï¼Œä½ æ¨å¾—è²·éº¼ï¼Ÿ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/57bf816163104c17a69e5ca301be7bb3 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/4ad8b035.html title=å‹•è¼’ä¸Šç™¾å¡Šçš„é±’é­šç§‹æµ·æ£ ï¼Œé€™ç¨®ç¶²ç´…æ¤ç‰©å¾ˆå®¹æ˜“ç¹æ®–ï¼Œä½ æ¨å¾—è²·éº¼ï¼Ÿ>å‹•è¼’ä¸Šç™¾å¡Šçš„é±’é­šç§‹æµ·æ£ ï¼Œé€™ç¨®ç¶²ç´…æ¤ç‰©å¾ˆå®¹æ˜“ç¹æ®–ï¼Œä½ æ¨å¾—è²·éº¼ï¼Ÿ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/d64413e7.html alt=é€™ç¨®ç§‹æµ·æ£ è¢«ç¨±ç‚ºèŠ±ä¸­è²´å¦ƒï¼ŒèŠ±ç¹è‰²è±”é‚„ä¸å¤ªå¬Œæ°£ï¼Œä¾†çœ‹çœ‹æ˜¯å“ªä¸€ç¨® class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/dfic-imagehandler/da8abdc7-162d-482a-8d32-4c8073c75b69 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/d64413e7.html title=é€™ç¨®ç§‹æµ·æ£ è¢«ç¨±ç‚ºèŠ±ä¸­è²´å¦ƒï¼ŒèŠ±ç¹è‰²è±”é‚„ä¸å¤ªå¬Œæ°£ï¼Œä¾†çœ‹çœ‹æ˜¯å“ªä¸€ç¨®>é€™ç¨®ç§‹æµ·æ£ è¢«ç¨±ç‚ºèŠ±ä¸­è²´å¦ƒï¼ŒèŠ±ç¹è‰²è±”é‚„ä¸å¤ªå¬Œæ°£ï¼Œä¾†çœ‹çœ‹æ˜¯å“ªä¸€ç¨®</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/345a5d9f.html alt=æ³¨æ„ï¼é€™ç¨®æ³¡æ‰“ç²‰åƒè¬ä¸èƒ½ç”¨ï¼Œå¦å‰‡å°‡è¢«åˆ¤å…¥ç„ï¼ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/ddc03f92e3da46a5b0ac5cbf80466043 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/345a5d9f.html title=æ³¨æ„ï¼é€™ç¨®æ³¡æ‰“ç²‰åƒè¬ä¸èƒ½ç”¨ï¼Œå¦å‰‡å°‡è¢«åˆ¤å…¥ç„ï¼>æ³¨æ„ï¼é€™ç¨®æ³¡æ‰“ç²‰åƒè¬ä¸èƒ½ç”¨ï¼Œå¦å‰‡å°‡è¢«åˆ¤å…¥ç„ï¼</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/07d16e44.html alt=é«˜é€Ÿå…¬è·¯é–‹è»Šï¼Œé‡åˆ°é€™ç¨®æƒ…æ³ï¼Œåˆ°åº•æ‡‰è©²å¾å“ªé‚Šè»Šé“è¶…è»Šï¼Ÿ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/fac013e6f37449be93343c6c4d009a3f style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/07d16e44.html title=é«˜é€Ÿå…¬è·¯é–‹è»Šï¼Œé‡åˆ°é€™ç¨®æƒ…æ³ï¼Œåˆ°åº•æ‡‰è©²å¾å“ªé‚Šè»Šé“è¶…è»Šï¼Ÿ>é«˜é€Ÿå…¬è·¯é–‹è»Šï¼Œé‡åˆ°é€™ç¨®æƒ…æ³ï¼Œåˆ°åº•æ‡‰è©²å¾å“ªé‚Šè»Šé“è¶…è»Šï¼Ÿ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/a4824300.html alt=å¦‚æœé ­èƒå‰–è…¹ç”¢æ˜¯é€™ç¨®åˆ‡å£ï¼ŒäºŒèƒé †ç”¢çš„æ©Ÿç‡æ›´å¤§ï¼Œä½ æ˜¯å—ï¼Ÿ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/pgc-image/1536826493403e2064b2c5d style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/a4824300.html title=å¦‚æœé ­èƒå‰–è…¹ç”¢æ˜¯é€™ç¨®åˆ‡å£ï¼ŒäºŒèƒé †ç”¢çš„æ©Ÿç‡æ›´å¤§ï¼Œä½ æ˜¯å—ï¼Ÿ>å¦‚æœé ­èƒå‰–è…¹ç”¢æ˜¯é€™ç¨®åˆ‡å£ï¼ŒäºŒèƒé †ç”¢çš„æ©Ÿç‡æ›´å¤§ï¼Œä½ æ˜¯å—ï¼Ÿ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/9bbb8dcd.html alt=é€™ç¨®æ¶²å£“æ³µæ²’è¦‹éï¼Ÿå–®å‘çƒé–¥å¼è¶…é«˜å£“è»¸å‘æŸ±å¡æ³µ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/15221556500026cae5bad53 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/9bbb8dcd.html title=é€™ç¨®æ¶²å£“æ³µæ²’è¦‹éï¼Ÿå–®å‘çƒé–¥å¼è¶…é«˜å£“è»¸å‘æŸ±å¡æ³µ>é€™ç¨®æ¶²å£“æ³µæ²’è¦‹éï¼Ÿå–®å‘çƒé–¥å¼è¶…é«˜å£“è»¸å‘æŸ±å¡æ³µ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/5b504eaf.html alt=ä½ ç…å•¥ï¼Ÿåˆ¥çœ‹å°é´æˆ‘å‘†èŒé•·å¤§å¯æ˜¯çŒ›ç¦½ï¼æµ™æ±Ÿæœ‰äººæ’¿åˆ°é€™ç¨®é³¥ï¼Œé—œæ–¼å®ƒã€Šè©©ç¶“ã€‹éƒ½æé class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/pgc-image/RyRw5A3AI4WIcX style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/5b504eaf.html title=ä½ ç…å•¥ï¼Ÿåˆ¥çœ‹å°é´æˆ‘å‘†èŒé•·å¤§å¯æ˜¯çŒ›ç¦½ï¼æµ™æ±Ÿæœ‰äººæ’¿åˆ°é€™ç¨®é³¥ï¼Œé—œæ–¼å®ƒã€Šè©©ç¶“ã€‹éƒ½æé>ä½ ç…å•¥ï¼Ÿåˆ¥çœ‹å°é´æˆ‘å‘†èŒé•·å¤§å¯æ˜¯çŒ›ç¦½ï¼æµ™æ±Ÿæœ‰äººæ’¿åˆ°é€™ç¨®é³¥ï¼Œé—œæ–¼å®ƒã€Šè©©ç¶“ã€‹éƒ½æé</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/689e70a3.html alt=é€™ç¨®åŸç”Ÿæ…‹çš„ç¾å‘³ç¦å®‰äººå¹¾ä¹éƒ½æ„›åƒï¼Œä½ æµå£æ°´äº†å—ï¼Ÿ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/566800082c606fbe27ce style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/689e70a3.html title=é€™ç¨®åŸç”Ÿæ…‹çš„ç¾å‘³ç¦å®‰äººå¹¾ä¹éƒ½æ„›åƒï¼Œä½ æµå£æ°´äº†å—ï¼Ÿ>é€™ç¨®åŸç”Ÿæ…‹çš„ç¾å‘³ç¦å®‰äººå¹¾ä¹éƒ½æ„›åƒï¼Œä½ æµå£æ°´äº†å—ï¼Ÿ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/918a88c3.html alt=ç­‰è·é›¢å¤–äº¤ï¼Œé€™ç¨®å¤¾ç¸«ä¸­çš„ç”Ÿå­˜ç­–ç•¥ï¼Œé«”ç¾äº†åšäººçš„å¤§æ™ºæ…§ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/dfic-imagehandler/cd54c748-3fa4-4d5d-b21c-2bb0f18d66bf style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/918a88c3.html title=ç­‰è·é›¢å¤–äº¤ï¼Œé€™ç¨®å¤¾ç¸«ä¸­çš„ç”Ÿå­˜ç­–ç•¥ï¼Œé«”ç¾äº†åšäººçš„å¤§æ™ºæ…§>ç­‰è·é›¢å¤–äº¤ï¼Œé€™ç¨®å¤¾ç¸«ä¸­çš„ç”Ÿå­˜ç­–ç•¥ï¼Œé«”ç¾äº†åšäººçš„å¤§æ™ºæ…§</a></li><hr></ul></section><section class=widget><h3 class=widget-title>å…¶ä»–</h3><ul class=widget-list><li><a href=TOS.html>ä½¿ç”¨æ¢æ¬¾</a></li><li><a href=CommentPolicy.html>ç•™è¨€æ”¿ç­–</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>DMCA</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>è¯çµ¡æˆ‘å€‘</a></li></ul></section></div></div></div></div><footer id=footer><div class=container>&copy; 2020 <a href>æå®¢å¿«è¨Š</a></div></footer><script type=text/javascript>window.MathJax={tex2jax:{inlineMath:[['$','$']],processEscapes:true}};</script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-MML-AM_CHTML" async></script><a id=rocket href=#top></a><script type=text/javascript src=https://kknews.cf/js/totop.js async></script><script type=text/javascript src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5e508ed9e4e698bb"></script></body></html>